Health Canada To Review Adcetris for Hodgkin's, ALCL

Seattle Genetics is announcing that the required validation period has ended and Health Canada has accepted the company's New Drug Submission (NDS) for review for the antibody drug conjugate Adcetris (brentuximab vedotin) for use against relapsed Hodgkin's lymphoma and for systemic anaplastic large cell lymphoma (ALCL).

The NDS is based on data from a pivotal trial in patients with relapsed or refractory Hodgkin's following an autologous stem cell transplantation, and another pivotal trial in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Health Canada intends to review the NDS under its policy of Notice of Compliance with Conditions (NOC/c). This policy is intended for drugs or treatments that are either meant for conditions for which no other treatment exists in Canada, or for treatments that represent a substantial improvement over existing treatments.

"Data from the pivotal clinical trials of Adcetris in relapsed HL and sALCL demonstrated a high objective response rate and manageable safety profile in heavily pre-treated patients," said Joseph M. Connors, M.D., FRCPC, Clinical Director, Center for Lymphoid Cancer at BC Cancer Agency in Vancouver, Canada. "If approved in Canada, Adcetris would constitute a major step forward in how we are able to treat these patients."

Source: MarketWatch

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...